Testing effectiveness (Phase 2)Study completedNCT01298570
What this trial is testing
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Who this might be right for
Colorectal Cancer Metastatic
UNC Lineberger Comprehensive Cancer Center 181